newsfilter
← Latest News
Business Wire·

Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum

  • Travere Therapeutics, Inc. (NASDAQ: TVTX) will present at the Stifel 2026 Virtual Immunology & Inflammation Forum.
  • The presentation is scheduled for Thursday, September 24, 2026, at 10:30 a.m. ET.
  • A live webcast will be accessible via the Investor page at ir.travere.com/events-and-presentations.
  • A replay of the event will remain available for up to 30 days following the presentation.
  • Travere is a biopharmaceutical company focused on developing therapies for rare diseases.